Hodgkins - update on treatment strategies in children and adolescents
Hodgkins - update on treatment strategies in children and adolescents
Use of novel agents in childhood ALL
Oncology for children: what can be done when resources are scarce?
Radiotherapy in Hogkin lymphoma: reducing risk in later life
Relapsed Hodgkin lymphoma in PET positive patients
Comment on RESONATE2 and CLL115 trials
Clinical cases employing novel agents in Hodgkin lymphoma
Current trials in chronic lymphocytic leukaemia
Microenvironment of chronic lymphocytic leukaemia
Chronic lymphocytic leukaemia: Transition to a new era
Ibrutinib as a frontline therapy in RESONATE2 trials for CLL
The role of the microenvironment and novel therapies in CLL
AML17 Trial results: maximum dosage of daunorubicin in AML
AML during pregancy
Germ line predisposition to leukaemia
The future of haematopathology
Frontline therapy in young patients with myeloma
Genomics of childhood ALL
BSH 2016: Expert discussion on idelalisib
BSH 2016: Expert discussion on front line care in CLL